ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1098

Interleukin-1 Reciprocally Regulates Interferon-Gamma Induced B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) and Interleukin-6 in Human Synovial Fibroblasts

Georg Pongratz1, Rainer Straub2 and Torsten Lowin3, 1Rheumatology - Hiller Research Center Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany, 2Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine, University Hospital Regensburg, Regensburg, Germany, 3Internal Medicine I, University Hospital Regensburg, Regensburg, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: BAFF, interferons, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: B cell Biology and Targets in Rheumatolid Arthritis and other Autoimmune Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: B cell activating factor of the tumor necrosis factor family (BAFF) and interleukin-6 (IL-6) are cytokines important for the stimulation and survival of autoreactive B cells and plasma cells, respectively, and play a role in several autoimmune diseases, e.g. autoimmune arthritis. It is known that synovial fibroblasts (SFs) are capable of producing BAFF and IL-6 and therefore provide survival signals to autoreactive B cells and plasma cells in the joint. Therefore, we wanted to better characterize inflammatory stimuli that modulate BAFF and IL-6 in SFs.

Methods: Fibroblasts isolated from synovial tissue of RA (n=10) and OA (n=10) patients were cultured in the presence or absence of different stimuli (interferon (IFN)g and interleukin (IL)-1). BAFF was determined by ELISA. Levels of phosphorylated and total STAT1 and STAT3 were determined by western blotting.

Results: IFN in a concentration-dependent manner induced BAFF and IL-6 in RA and OA fibroblasts. Since inflammation usually leads to hypoxic conditions, we also compared IFN-g-induced cytokine production in RA and OA SFs under normoxic and hypoxic (oxygen content 2%) culture conditions.  IFN-induced BAFF was augmented in OA (p<0.001) and RA (p<0.01) SFs under hypoxic conditions, whereas there was no oxygen dependency of IFN-induced IL-6. IFN leads to a strong phosphorylation of STAT1 but to a reduction in phosphorylated STAT3 in RA and OA SFs. However, it has been suggested that concomitant phosphorylation of STAT3 further augments BAFF production. Therefore, we wanted to test if concomitant IL-1, which leads to phosphorylation of STAT3, further increases IFN-induced BAFF and/or IL-6 in SFs. However, in the presence of IL-1, INF-induced BAFF was inhibited (p>0.001), whereas IFN-induced IL-6 was increased (p<0.001) in a concentration dependent manner independent of oxygen content in both, OA and RA fibroblasts. Furthermore, inhibition of pSTAT3 resulted in further augmentation of IFN-induced BAFF (p=0.003) and decrease of IFN-induced IL-6 (p=0.04). 

Conclusion: Taken together, BAFF and IL-6 production in synovial fibroblasts are induced by IFN and reciprocally regulated by IL-1 in a STAT3 dependent manner. In contrast to IL-6, IFN-induced BAFF can be further augmented by hypoxia. These results give further insight in local regulation of the microenvironment provided for B cells in the arthritic joint.


Disclosure: G. Pongratz, None; R. Straub, None; T. Lowin, None.

To cite this abstract in AMA style:

Pongratz G, Straub R, Lowin T. Interleukin-1 Reciprocally Regulates Interferon-Gamma Induced B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) and Interleukin-6 in Human Synovial Fibroblasts [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/interleukin-1-reciprocally-regulates-interferon-gamma-induced-b-cell-activating-factor-of-the-tumor-necrosis-factor-family-baff-and-interleukin-6-in-human-synovial-fibroblasts/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interleukin-1-reciprocally-regulates-interferon-gamma-induced-b-cell-activating-factor-of-the-tumor-necrosis-factor-family-baff-and-interleukin-6-in-human-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology